{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:05:06Z","timestamp":1769558706589,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00520-021-06023-0","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T23:02:49Z","timestamp":1611961369000},"page":"4723-4732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Severity of constipation related to palonosetron during first-line chemotherapy: a retrospective observational study"],"prefix":"10.1007","volume":"29","author":[{"given":"Sakiko","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Furuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintaro","family":"Sogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsujiro","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Sueoka-Aragane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Noshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Kuratomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"6023_CR1","doi-asserted-by":"publisher","first-page":"iv111","DOI":"10.1093\/annonc\/mdy148","volume":"29","author":"PJ Larkin","year":"2018","unstructured":"Larkin PJ, Cherny NI, Carpia DL, Guglielmo M, Ostgathe C, Scotte F, Ripamonti CI, ESMO Guidelines Committee (2018) Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29:iv111\u2013iv125","journal-title":"Ann Oncol"},{"key":"6023_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00520-019-05016-4","volume":"28","author":"A Davies","year":"2020","unstructured":"Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23\u201333","journal-title":"Support Care Cancer"},{"issue":"11-12","key":"6023_CR3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1365-2036.2005.02696.x","volume":"22","author":"BD Cash","year":"2005","unstructured":"Cash BD, Chey WD (2005) Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther 22(11-12):1047\u20131060","journal-title":"Aliment Pharmacol Ther"},{"key":"6023_CR4","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1345\/aph.1D191","volume":"38","author":"M Constenla","year":"2004","unstructured":"Constenla M (2004) 5-HT3 receptor antagonists for prevention of late acute-onset emesis. Ann Pharmacother 38:1683\u20131691","journal-title":"Ann Pharmacother"},{"key":"6023_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1476-5381.1995.tb13282.x","volume":"114","author":"EH Wong","year":"1995","unstructured":"Wong EH, Clark R, Leung E, Loury D, Bonhaus DW, Jakeman L, Parnes H, Whiting RL, Eglen RM (1995) The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol 114:851\u2013859","journal-title":"Br J Pharmacol"},{"key":"6023_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.6004\/jnccn.2017.0117","volume":"15","author":"MJ Berger","year":"2017","unstructured":"Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M (2017) NCCN Guidelines insights: Antiemesis, Version 2.2017. J Natl Compr Cancer Netw 15:883\u2013893","journal-title":"J Natl Compr Cancer Netw"},{"key":"6023_CR7","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","volume":"35","author":"PJ Hesketh","year":"2017","unstructured":"Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA et al (2017) American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35:3240\u20133261","journal-title":"J Clin Oncol"},{"key":"6023_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00520-016-3313-0","volume":"25","author":"J Herrstedt","year":"2017","unstructured":"Herrstedt J, Roila F, Warr D, Celio L, Navari RM, Hesketh PJ, Chan A, Aapro MS (2017) 2016 Updated MASCC\/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy. Support Care Cancer 25:277\u2013288","journal-title":"Support Care Cancer"},{"key":"6023_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-015-0852-1","volume":"21","author":"H Takeuchi","year":"2016","unstructured":"Takeuchi H, Saeki T, Aiba K, Tamura K, Aogi K, Eguchi K, Okita K, Kagami Y, Tanaka R, Nakagawa K, Fujii H, Boku N, Wada M, Akechi T, Udagawa Y, Okawa Y, Onozawa Y, Sasaki H, Shima Y, Shimoyama N, Takeda M, Nishidate T, Yamamoto A, Ikeda T, Hirata K (2016) Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary. Int J Clin Oncol 21:1\u201312","journal-title":"Int J Clin Oncol"},{"key":"6023_CR10","unstructured":"Palonosetron hydrochloride drug package insert: https:\/\/www.info.pmda.go.jp\/go\/pack\/2391404A1020_1_06\/?view=frame&style=XML&lang=ja. Accessed 8th December 2020"},{"key":"6023_CR11","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1093\/annonc\/mdp195","volume":"20","author":"M Maemondo","year":"2009","unstructured":"Maemondo M, Masuda N, Sekine I, Kubota K, Segawa Y, Shibuya M, Imamura F, Katakami N, Hida T, Takeo S (2009) A Phase II study ofpalonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy. Ann Oncol 20:1860\u20131866","journal-title":"Ann Oncol"},{"key":"6023_CR12","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/annonc\/mdp243","volume":"20","author":"Y Segawa","year":"2009","unstructured":"Segawa Y, Aogi K, Inoue K, Sano M, Sekine I, Tokuda Y, Isobe H, Ogura T, Tsuboi M, Atagi S (2009) A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy. Ann Oncol 20:1874\u20131880","journal-title":"Ann Oncol"},{"key":"6023_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1470-2045(08)70313-9","volume":"10","author":"M Saito","year":"2009","unstructured":"Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T, Mitsuhashi (2009) Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol 10:115\u2013124","journal-title":"Lancet Oncol"},{"key":"6023_CR14","unstructured":"Summary basis of palonosetron approval: https:\/\/www.pmda.go.jp\/drugs\/2010\/P201000003\/400107000_22200AMX00247_A100_1.pdf. Accessed 8th December 2020"},{"key":"6023_CR15","first-page":"G498","volume":"275","author":"ES Bj\u00f6rnsson","year":"1998","unstructured":"Bj\u00f6rnsson ES, Chey WD, Ladabaum U, Woods ML, Hooper FG, Owyang C, Hasler WL (1998) Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex. Am J Phys 275:G498\u2013G505","journal-title":"Am J Phys"},{"key":"6023_CR16","doi-asserted-by":"publisher","first-page":"G400","DOI":"10.1152\/ajpgi.00082.2001","volume":"283","author":"ES Bj\u00f6rnsson","year":"2002","unstructured":"Bj\u00f6rnsson ES, Chey WD, Hooper F, Woods ML, Owyang C, Hasler WL (2002) Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT3 pathways. Am J Physiol Gastrointest Liver Physiol 283:G400\u2013G407","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"6023_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1365-2036.1998.00375.x","volume":"12","author":"M Delvaux","year":"1998","unstructured":"Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J (1998) Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 12:849\u2013855","journal-title":"Aliment Pharmacol Ther"},{"key":"6023_CR18","volume-title":"Evidence-based clinical practice guidelines for chronic constipation 2017, ed. Research Society for the Diagnosis and Treatment of Chronic Constipation","author":"The Japanese Society of Gastroenterology","year":"2017","unstructured":"The Japanese Society of Gastroenterology (2017) Evidence-based clinical practice guidelines for chronic constipation 2017, ed. Research Society for the Diagnosis and Treatment of Chronic Constipation. Affiliated to The Japanese Society of Gastroenterology in Japanese, Nankodo, Tokyo"},{"key":"6023_CR19","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00520-010-1051-2","volume":"19","author":"EA Laugsand","year":"2011","unstructured":"Laugsand EA, Jakobsen G, Kaasa S, Klepstad P (2011) Inadequate symptom control in advanced cancer patients across Europe. Support Care Cancer 19:2005\u20132014","journal-title":"Support Care Cancer"},{"key":"6023_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1634\/theoncologist.2010-0198","volume":"16","author":"Z Likun","year":"2011","unstructured":"Likun Z, Xiang J, Yi B, Xin D, Tao ZL (2011) A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults. Oncologist 16:207\u2013216","journal-title":"Oncologist"},{"key":"6023_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/0269216308096908","volume":"22","author":"PJ Larkin","year":"2008","unstructured":"Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW, European Consensus Group on Constipation in Palliative Care (2008) The management of constipation in palliative care: clinical practice recommendations. Palliat Med 22:796\u2013807","journal-title":"Palliat Med"},{"key":"6023_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jpainsymman.2015.02.019","volume":"50","author":"A Davies","year":"2015","unstructured":"Davies A, Webber K (2015) Stercoral perforation of the colon: a potentially fatal complication of opioid-induced constipation. J Pain Symptom Manag 50:260\u2013262","journal-title":"J Pain Symptom Manag"},{"key":"6023_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ijcard.2003.12.014","volume":"98","author":"N Yamada","year":"2005","unstructured":"Yamada N, Nakamura M, Ishikura K, Ota M, Yazu T, Ota S, Ito M, Fujioka H, Isaka N, Nakano T (2005) Triggers of acute pulmonary thromboembolism developed in hospital, with focusing on toilet activities as triggering acts. Int J Cardiol 98:409\u2013411","journal-title":"Int J Cardiol"},{"key":"6023_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2013.08.049","volume":"722","author":"C Rojas","year":"2014","unstructured":"Rojas C, Raje M, Tsukamoto T, Slusher BS (2014) Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis. Eur J Pharmacol 722:26\u201337","journal-title":"Eur J Pharmacol"},{"key":"6023_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejphar.2012.09.008","volume":"698","author":"NA Darmani","year":"2013","unstructured":"Darmani NA, Dey D, Chebolu S, Amos B, Kandpal R, Alkam T (2013) Cisplatin causes over-expression of tachykinin NK(1) receptors and increases ERK1\/2- and PKA- phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem. Eur J Pharmacol 698:161\u2013169","journal-title":"Eur J Pharmacol"},{"key":"6023_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2004.04.072","volume":"365","author":"WP Hu","year":"2004","unstructured":"Hu WP, You XH, Guan BC, Ru LQ, Chen JG, Li ZW (2004) Substance P potentiates 5-HT3 receptor-mediated current in rat trigeminal ganglion neurons. Neurosci Lett 365:147\u2013152","journal-title":"Neurosci Lett"},{"key":"6023_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0014-2999(01)01297-3","volume":"428","author":"M Minami","year":"2001","unstructured":"Minami M, Endo T, Yokota H, Ogawa T, Nemoto M, Hamaue N, Hirafuji M, Yoshioka M, Nagahisa A, Andrews PL (2001) Effects of CP-99, 994, a tachykinin NK1 receptor antagonist, on abdominal afferent vagal activity in ferrets: evidence for involvement of NK1 and 5-HT3 receptors. Eur J Pharmacol 428:215\u2013220","journal-title":"Eur J Pharmacol"},{"key":"6023_CR28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/annonc\/mdu096","volume":"25","author":"RJ Gralla","year":"2014","unstructured":"Gralla RJ, Bosnjak SM, Hontsa A, Balser C, Rizzi G, Rossi G, Borroni ME, Jordan K (2014) A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy. Ann Oncol 25:1333\u20131339","journal-title":"Ann Oncol"},{"key":"6023_CR29","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/annonc\/mdw220","volume":"27","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Yamanaka T, Hashimoto H, Shimada Y, Arata K, Matsui R, Goto K, Takiguchi T, Ohyanagi F, Kogure Y, Nogami N, Nakao M, Takeda K, Azuma K, Nagase S, Hayashi T, Fujiwara K, Shimada T, Seki N, Yamamoto N (2016) Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study. Ann Oncol 27:1601\u20131606","journal-title":"Ann Oncol"},{"key":"6023_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.autneu.2004.05.007","volume":"113","author":"M Hanani","year":"2004","unstructured":"Hanani M, Fellig Y, Udassin R, Freund HR (2004) Age-related changes in the morphology of the myenteric plexus of the human colon. Auton Neurosci 113:71\u201378","journal-title":"Auton Neurosci"},{"issue":"7","key":"6023_CR31","doi-asserted-by":"publisher","first-page":"e746","DOI":"10.1111\/j.1365-2982.2008.01245.x","volume":"21","author":"CE Bernard","year":"2009","unstructured":"Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, Lurken MS, Schmalz PF, Roeder JL, Linden D, Cima RR, Dozois EJ, Larson DW, Camilleri M, Zinsmeister AR, Pozo MJ, Hicks GA, Farrugia G (2009) Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil 21(7):e746\u2013e746","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"6023_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1365-2982.1999.00145.x","volume":"11","author":"E Lagier","year":"1999","unstructured":"Lagier E, Delvaux M, Vellas B, Fioramonti J, Bueno L, Albarede JL, Frexinos J (1999) Influence of age on rectal tone and sensitivity to distension in healthy subjects. Neurogastroenterol Motil 11(2):101\u2013107","journal-title":"Neurogastroenterol Motil"},{"key":"6023_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/DCR.0b013e3181fd2356","volume":"54","author":"I Kepenekci","year":"2011","unstructured":"Kepenekci I, Keskinkilic B, Akinsu F, Cakir P, Elhan AH, Erkek AB, Kuzu MA (2011) Prevalence of pelvic floor disorders in the female population and the impact of age, mode of delivery, and parity. Dis Colon Rectum 54:85\u201394","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"6023_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.gtc.2009.06.001","volume":"38","author":"EP Bouras","year":"2009","unstructured":"Bouras EP, Tangalos EG (2009) Chronic constipation in the elderly. Gastroenterol Clin N Am 38(3):463\u2013448","journal-title":"Gastroenterol Clin N Am"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06023-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T03:31:37Z","timestamp":1624851097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06023-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6023"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06023-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"9 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Clinical Research Ethics Review Committee of Saga University Hospital (2017-12-11).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study is a retrospective observational study, carried out by the opt-out method of our hospital website.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All co-authors agreed to the final version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SK, KH, KO, TF, RS, KT, MT, AK, AN, NS-A YK, MY, MN, KA, YY, and HI declare that they have no conflict of interest. HN and SK received research funding from Taiho Pharmaceutical company. SK received research funding from Ono Pharmaceutical company.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}